US2017002337A1PendingUtilityA1

Fusion Enzymes

Assignee: GLYKOS FINLAND OYPriority: Nov 24, 2010Filed: Jul 8, 2016Published: Jan 5, 2017
Est. expiryNov 24, 2030(~4.3 yrs left)· nominal 20-yr term from priority
C12Y 204/01143C12N 9/1051C12N 15/80C12Y 204/01101C12N 1/14C12P 21/005C12N 9/10C12N 5/10C12P 19/18C07K 2319/03C12P 21/00Y02P20/52
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure relates to recombinant proteins having N-acetylglucosaminyltransferase activity. The present disclosure further relates to methods for producing complex N-glycans including the steps of providing host cells containing such recombinant proteins and culturing the host cells such that the recombinant proteins are expressed.

Claims

exact text as granted — not AI-modified
1 - 69 . (canceled) 
     
     
         70 . A fungal host cell comprising an expression vector comprising a polynucleotide encoding a fusion protein comprising an N-acetylglucosaminyltransferase I catalytic domain and an N-acetylglucosaminyltransferase II catalytic domain, wherein the N-acetylglucosaminyltransferase II catalytic domain is positioned N-terminal to the N-acetylglucosaminyltransferase I catalytic domain, and wherein the fusion protein catalyzes the transfer of N-acetylglucosamine to a terminal Manα3 residue and N-acetylglucosamine to a terminal Manα6 residue of an acceptor glycan, wherein the acceptor glycan is attached to a heterologous polypeptide. 
     
     
         71 . The fungal host cell of claim  1 , wherein the host cell is selected from the group consisting of  Trichoderma, Aspergillus, Fusarium, Chrysosporium, Magnaporthe, Mycellopthora, Neurospora,  or  Penicillium.

Join the waitlist — get patent alerts

Track US2017002337A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.